open.spotify.com
Mar 17, 2026, 15:43
How Clinicians Navigate the Challenge of Balancing Clotting and Bleeding in CAD – Vasculearn Network
Vasculearn Network shared a post on LinkedIn:
“Antithrombotic therapy in coronary artery disease isn’t one-size-fits-all anymore.
Heather M. Johnson, Ty J. Gluckman and Davide Capodanno come together in the latest episode of Clot, Clot, Who’s There? to chat about how clinicians are navigating the everyday challenge of balancing clotting and bleeding risk.
From the evolving role of aspirin to P2Y12 monotherapy, dual pathway inhibition, and managing CAD with AFib, the conversation highlights a simple shift in thinking:
Less of ‘What should everyone get?’
More of ‘What’s right for the patient in front of me?’
Stay updated with Hemostasis Today.
-
Mar 17, 2026, 15:45Wolfgang Miesbach: Six Years of Normal Factor VIII After a Single Gene Therapy in Hemophilia A
-
Mar 17, 2026, 15:44Jan Sloves: Venous Phasicity and the Role of IVC Mechanics
-
Mar 17, 2026, 15:41Beverly G. Tchang: Lipid-Lowering Therapy in Women During Pregnancy and Lactation
-
Mar 17, 2026, 15:34Folusho Adeosun: Raising Fetal Hemoglobin as a Powerful Protective Shield in Sickle Cell Disease
-
Mar 17, 2026, 15:28Aafreen Kotadiya: Why a Great Blood Bank Team is a Rare and Powerful Asset in Transfusion Medicine
-
Mar 17, 2026, 15:26Nathan Connell: $50 Million Gift to Advance Cell and Gene Therapy at Mass General Brigham
-
Mar 17, 2026, 15:10Peter Zdziarski: Standing Together for Ultra Rare Bleeding Disorders Awareness Day
-
Mar 17, 2026, 14:58Heghine Khachatryan: PFO, Cryptogenic Stroke, and Factor V Leiden – Closure or Lifelong Anticoagulation?
-
Mar 17, 2026, 14:56Mahesan Subramaniam: A Visual Guide to Heart Valve Disease